Form D · Pharmaceuticals
NAPO PHARMACEUTICALS INC
San Francisco, CA · CIK 0001188290
Offering snapshot reported Jun 6, 2014 · SEC filing
- Reported sold
- $138K Offering amount: $138K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 18, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2014 | Initial | $137,500 | No comparison | 3 | SEC filing |
| Oct 27, 2011 | Initial | $3,087,500 | No comparison | 5 | SEC filing |
| Jun 22, 2011 | Initial | $2,996,869 | No comparison | 10 | SEC filing |
| Oct 27, 2010 | Initial | $3,360,000 | No comparison | 10 | SEC filing |
| Jul 9, 2009 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Mar 16, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 16, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 16, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 13, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-218681
Warrants and the underlying common stock issuable upon exercise thereof
Source: Form D, filed Jun 6, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pravi Chaturvedi | Executive |
| Pravin Chaturvedi | Executive |
| Lisa Conte | Director, Executive |
| Dennis Fenton | Director |
| Richard Fields | Director |
| Steven King | Executive |
| Joshua Mailman | Director |
| Gregory Stock | Director |
| Charles Thompson | Executive |
| Thomas Van Dyck | Director |
| Jack Van Hulst | Director |
| Sir William Young | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
185 Berry Street, Suite 1300
San Francisco, CA, 94107
San Francisco, CA, 94107